Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending	PI Organization	Title	Grant Number	Initiative	Program Official
Czerniak, Bogdan A	University Of Tx Md Anderson Can Ctr United States	Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy.	1P01CA296429-01A1		Howard L. Parnes, M.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms	5R01CA272147-03	PAR-21-329 (R01 Clinical Trial Optional)	Rachel Altshuler, Ph.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy	1R21CA296516-01		Rachel Altshuler, Ph.D.
Daniel-Macdougall, Carrie	University Of Tx Md Anderson Can Ctr United States	Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma	5R01CA291965-02		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Dashwood, Roderick H	Texas A&M University Health Science Ctr United States	Immunoepigenetic targeting of MHC regulators in FAP	5R01CA257559-03
Debes, Jose Daniel	University Of Minnesota United States	Biomarkers for Early Detection of Hepatitis B-Related Hepatocellular Carcinoma in Hispanics	1R37CA297814-01		Sidney Fu, M.D.
Delaney, Joe R	Medical University Of South Carolina United States	Biologic rationale of fallopian tube removal to prevent uterine serous carcinoma	1R21CA292343-01A1		Goli Samimi, Ph.D., M.P.H.
Demb, Joshua Brian	University Of California, San Diego United States	Optimal early colorectal cancer screening initiation	4R00CA267181-03		Claire Zhu, Ph.D.
Demehri, Shadmehr	Massachusetts General Hospital United States	Immunosurveillance of breast glands with oncogenic germline mutations	5UG3CA290300-02		Altaf Mohammed, Ph.D.
Deng, Gary E	University Of California-Irvine United States	Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial	7R21CA286330-03		Goli Samimi, Ph.D., M.P.H.